Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial

<table>Fasting serum glucose (mg/dL). Fasting serum glucose was significantly decreased in the goshajinkigan group compared with the baseline value at the 36th, 42nd, 48th, 54th, and 60th months.</table>

Evidence-Based Complementary and Alternative Medicine

fig7

Figure 7

Figure 7: Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial 